News
12 Health Care Stocks Moving In Thursday's After-Market Session
11 Apr 24
Movers
12 Health Care Stocks Moving In Friday's After-Market Session
22 Mar 24
Movers
12 Health Care Stocks Moving In Thursday's Pre-Market Session
14 Mar 24
Movers
12 Health Care Stocks Moving In Wednesday's After-Market Session
13 Mar 24
Movers
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Mar 24
Movers
Bright Green Corp Signed An Agreement With Dalsem Greenhouse Technologies BV For $250M For Expansion Of Its Controlled Substances Drug Production Facility In Grants, New Mexico And Obtained $60M In Financing
12 Mar 24
News, Financing, Contracts
Bright Green Corporation Submits For DEA Registration For Production Of Schedule I And Schedule II Controlled Substances.
7 Mar 24
News
DEA Clears This NASDAQ-Traded 'Plant-Touching' Firm To Research And Produce Schedule I And II Plant-Based Drugs
23 Feb 24
12 Health Care Stocks Moving In Wednesday's After-Market Session
21 Feb 24
Movers
Top Cannabis Appointments You Should Know About: Aurora's New CFO And Other Changes
20 Feb 24
Cannabis, News, Entrepreneurship, Movers & Shakers
12 Health Care Stocks Moving In Friday's After-Market Session
16 Feb 24
Movers
12 Health Care Stocks Moving In Thursday's After-Market Session
8 Feb 24
Movers
Press releases
BRIGHT GREEN ANNOUNCES PLANS FOR $250 MILLION EXPANSION OF ITS CONTROLLED SUBSTANCES DRUG PRODUCTION FACILITY IN GRANTS, NEW MEXICO AND OBTAINS $60 MILLION IN FINANCING
12 Mar 24
Press Releases
BRIGHT GREEN CORPORATION GAINS MOMENTUM FOR THEIR "DRUGS MADE IN AMERICA" PLATFORM WITH APPROVAL FOR THE RESEARCH, PRODUCTION AND MANUFACTURING OF ALL SCHEDULE I AND SCHEDULE II PLANT-BASED DRUGS
22 Feb 24
Press Releases
BRIGHT GREEN CORPORATION ANNOUNCES CHANGES TO BOARD OF DIRECTORS
16 Feb 24
Press Releases